# ZORYVE
> **NDA215985** · New Drug Application · Sponsor: ARCUTIS · Approved 2022-07-29
## Drug
- **FDA Application Number:** NDA215985
- **Application type:** New Drug Application
- **Brand name:** ZORYVE
- **Generic name:** ROFLUMILAST
- **Active ingredients:** ROFLUMILAST
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ARCUTIS
- **Manufacturer:** Arcutis Biotherapeutics, Inc.
- **First approval:** 2022-07-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215985)
---
*AI Analytics · CC0 1.0*